PDF herunterladen
CC BY-NC-ND 4.0 · Journal of Health and Allied Sciences NU 2020; 10(03): 132-134
DOI: 10.1055/s-0040-1716601
Case Report

Drug-Induced Lupus Erythematosus Associated with Proton Pump Inhibitor

Manokaran Chinnusamy
1   Department of General Medicine, Sri Manakula Vinayagar Medical College and Hospital, Madagadipet, Pondicherry, India
,
Ram Arvind Viswanathan
1   Department of General Medicine, Sri Manakula Vinayagar Medical College and Hospital, Madagadipet, Pondicherry, India
,
Sathiyanarayanan Janakiraman
1   Department of General Medicine, Sri Manakula Vinayagar Medical College and Hospital, Madagadipet, Pondicherry, India
,
Roshna Elayidath
1   Department of General Medicine, Sri Manakula Vinayagar Medical College and Hospital, Madagadipet, Pondicherry, India
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Abstract

Drug-induced lupus erythematosus is an autoimmune phenomenon where the drug exposure leads to the development of systemic lupus erythematous like clinical features. Drug-induced lupus erythematosus can be divided into systemic lupus erythematous, subacute cutaneous lupus erythematous, and chronic cutaneous lupus erythematous. Here, we report a case of a 29-year-old female presented with systemic lupus erythematous due to chronic use of proton pump inhibitors, which is considered to be very rare.

Keywords

drug-induced lupus - pantoprazole - proton pump inhibitors


Publikationsverlauf

Artikel online veröffentlicht:
08. September 2020

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Hess E. Drug-related lupus. N Engl J Med 1988; 318 (22) 1460-1462
    CrossrefPubMedGoogle Scholar
  • 2 Hoffman BJ. Sensitivity to sulfadiazine resembling acute disseminated lupus erythematosus. Arch Derm Syphilol 1945; 51: 190-192
    CrossrefGoogle Scholar
  • 3 Dam C, Bygum A. Subacute cutaneous lupus erythematosus induced or exacerbated by proton pump inhibitors. Acta Derm Venereol 2008; 88 (01) 87-89
    CrossrefPubMedGoogle Scholar
  • 4 Yoshimasu T, Hiroi A, Uede K, Furukawa F. Discoid lupus erythematosus (DLE)-like lesion induced by uracil-tegafur (UFT). Eur J Dermatol 2001; 11 (01) 54-57
    PubMedGoogle Scholar
  • 5 Pramatarov KD. Drug-induced lupus erythematosus. Clin Dermatol 1998; 16 (03) 367-377
    CrossrefPubMedGoogle Scholar
  • 6 Antonov D, Kazandjieva J, Etugov D, Gospodinov D, Tsankov N. Drug-induced lupus erythematosus. Clin Dermatol 2004; 22 (02) 157-166
    CrossrefPubMedGoogle Scholar
  • 7 Sandholdt LH, Laurinaviciene R, Bygum A. Proton pump inhibitor-induced subacute cutaneous lupus erythematosus. Br J Dermatol 2014; 170 (02) 342-351
    CrossrefPubMedGoogle Scholar
  • 8 Solhjoo M, Ho CH, Chauhan K, Gossman W. Drug-Induced Lupus Erythematosus. Treasure Island: StatPearls Publishing; 2019
    Google Scholar